Celldex (CLDX) Tops Q2 EPS by 2c

August 8, 2016 4:11 PM

Celldex (NASDAQ: CLDX) reported Q2 EPS of ($0.32), $0.02 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $1.39 million versus the consensus estimate of $850 thousand.

For earnings history and earnings-related data on Celldex (CLDX) click here.



Next Articles